Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United Kingdom
/
Pharmaceuticals & Biotech
Create a narrative
Indivior Community
LSE:INDV Community
1
Narratives
written by author
0
Comments
on narratives written by author
17
Fair Values set
on narratives written by author
Create a narrative
Indivior
Popular
Undervalued
Overvalued
Community Investing Ideas
Indivior
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
SUBLOCADE Investments Will Improve Patient And Physician Experience
Key Takeaways Commercial investments and label updates for SUBLOCADE are expected to boost revenue growth and enhance patient and physician experience. Strategic reinvestments and U.S. market stabilization could strengthen revenue projections and profit margins for Indivior.
View narrative
UK£10.82
FV
21.7% undervalued
intrinsic discount
-1.14%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
1 day ago
author updated this narrative
Your Valuation for
INDV
INDV
Indivior
Your Fair Value
UK£
Current Price
UK£8.47
35.6% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-95m
1b
2015
2018
2021
2024
2025
2027
2030
Revenue US$1.2b
Earnings US$183.6m
Advanced
Set Fair Value